0.26 USD
▼-0.01-3.92%
盘后 0.23 0.00%
2026-09-16
市值
$12.82M
市盈率
—
EPS
-1.89
股息率
—
52 周区间
0.18 – 1.45
成交量
1.28M
Beta
0.65
目标价
1.53
52W 低 0.1852W 高 1.45
价格走势
公司简介
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is base...